on 05 Jan 2021
Last Applicant/ Owned by
No. 168 Dongping Street
Suzhou City
CN
215123
Serial Number
88177424 filed on 01st Nov 2018
Registration Number
6236173 registered on 05th Jan 2021
Correspondent Address
Anessa Owen Kramer
Filing Basis
1. intent to use
Disclaimer
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "SHENGWUZHIYAO"
The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT". The non-Latin characters in the mark transliterate to "XIN DA SHENG WU ZHI YAO" and this means "integrity", "action", "bio-pharmaceuticals" in English. Color is not claimed as a feature of the mark. THE NON-LATIN CHARACTERS THAT TRANSLITERATERead More
Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes
No 88177424
No Service/Collective Mark
No 235599438760
No
No
No
No
No
No
No
No
26.17.09 -
Curved line(s), band(s) or bar(s)
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
28.01.03 -
Japanese and Chinese characters Formerly Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters
The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT".
| Status Date | Action Taken |
|---|---|
| 05th Jan 2021 | REGISTERED-PRINCIPAL REGISTER |
| 20th Oct 2020 | PUBLISHED FOR OPPOSITION |
| 20th Oct 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 30th Sep 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Sep 2020 | 1(B) BASIS DELETED; NEW BASIS REQUESTED |
| 17th Sep 2020 | NOTICE OF ALLOWANCE CANCELLED |
| 11th Sep 2020 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
| 11th Sep 2020 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| 09th Sep 2020 | ASSIGNED TO PETITION STAFF |
| 24th Jul 2020 | TEAS PETITION TO AMEND BASIS RECEIVED |
